z-logo
open-access-imgOpen Access
Combination of peritumoral mast cells and T‐regulatory cells predicts prognosis of hepatocellular carcinoma
Author(s) -
Ju MinJie,
Qiu ShuangJian,
Gao Qiang,
Fan Jia,
Cai MingYan,
Li YiWei,
Tang ZhaoYou
Publication year - 2009
Publication title -
cancer science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.035
H-Index - 141
eISSN - 1349-7006
pISSN - 1347-9032
DOI - 10.1111/j.1349-7006.2009.01182.x
Subject(s) - hepatocellular carcinoma , medicine , tryptase , foxp3 , immunohistochemistry , milan criteria , tissue microarray , gastroenterology , oncology , pathology , immunology , immune system , mast cell , liver transplantation , transplantation
The peritumoral inflammatory environment is critical for the progression of intrahepatic recurrence of hepatocellular carcinoma (HCC) after curative resections. Here, we investigated the relevance of peritumoral mast cells (MCs) to HCC outcomes. Peritumoral tryptase + MCs in addition to Foxp3 + T‐regulatory cells (Tregs) were evaluated using immunohistochemistry enumeration in tissue microarrays containing 207 randomly selected HCC patients. Clinicopathological factors and postoperative outcomes were compared between high and low subgroups of MCs or Tregs. Compared to low denstiy, higher peritumoral MCs were associated with poorer clinical outcomes, and independently related to elevated 5‐year recurrence incidence (54.1% vs 39.2%, P  = 0.026). High‐dense MCs were especially related to increased probability of early recurrence (within 2 years) ( P  = 0.004). We also found that peritumoral Tregs were positively correlated with MCs in density ( r  = 0.353, P  < 0.001) and reversely related to HCC outcomes. Notably, MCs in combination with Tregs displayed better prognostic performances than MCs alone (area under curve [AUC] survival  = 0.629 vs 0.589, AUC recurrence  = 0.632 vs 0.591). Moreover, MCs were positively correlated to alanine aminotransferase, a serum inflammatory marker ( P  = 0.014). Therefore, peritumoral MCs are promising prognostic parameters for HCC mainly through inflammation response–related mechanisms, and we propose that MCs and Tregs may cooperate with each other and result in poorer prognosis. ( Cancer Sci 2009; 100: 1267–1274)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here